Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia

Similar Items

• Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation
  od: van Luijn, Marvin M., i dr.
  Izdano: (2012)
• Class II–Associated Invariant Chain Peptide Expression Represents a Novel Parameter for Flow Cytometric Detection of Acute Promyelocytic Leukemia
  od: van Luijn, Marvin M., i dr.
  Izdano: (2011)
• Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4(+) T-cell responses
  od: van Luijn, Marvin M., i dr.
  Izdano: (2010)
• Promiscuous Binding of Invariant Chain-Derived CLIP Peptide to Distinct HLA-I Molecules Revealed in Leukemic Cells
  od: van Luijn, Marvin M., i dr.
  Izdano: (2012)
• Minimal Residual Disease in Acute Myeloid Leukemia
  od: Hourigan, Christopher S., i dr.
  Izdano: (2013)